DiponEd BioIntelligence Embraces Value-Based Funding

DiponEd BioIntelligence has become a dominant player in the healthcare domain.

Bangalore, India, July 05, 2016 --(PR.com)-- With yet another successful year following, DiponEd BioIntelligence has become a dominant player in the healthcare domain by providing matchless collaboration solutions for large healthcare systems and acute care hospitals.

The nation's leading healthcare support partner, DiponEd BioIntelligence overwhelmingly embraced the initiative by Ministry of Human Resources Development for providing a value-based funding of about 300,000 USDs under Public Private Partnership R&D intended for developing novel personalized algorithms and products for new sorts of 3D printed Orthotics and Personalized Ortho Implants products.

The said products will be developed collectively by IIT Hyderabad and DiponEd's scientists, software engineers, tissue engineering team, and Biomedical engineering team. These products and services are planned to be launched in the Indian market along with all partner centers of DiponEd's personalized medicine clinics by 2017- 18.

This will also support the designing of custom-made implants for sports performance enhancement, sports injuries, orthopedic implants, join pain management, vascular issues, and other reconstructive surgeries in cancer etc. This will come forward as a savior for a lot of patients with unmet medical conditions which could only heal through a personalized treatment approach.

In the wake of Prime Minister Narender Modi’s initiative Make in India, DiponEd BioIntelligence is also actively seeking PPP partners with academia for numerous product development projects for personalized healthcare and cellular products.
Contact
Diponed
Prabhat kumar
080 2783 5022
diponed.com
ContactContact
Categories